How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

The Ban Artificial Superintelligence Act identifies real failures in AI governance. But its publicly released definition ...

It's not common for someone to find a python in their backyard or garage in Florida, but if they do there are steps to follow ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

The pioneering treatment makes it easier for traditional chemotherapy drugs to penetrate cancer cells. After the procedure, the reptile, named Jodie Foster, made a speedy recovery ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

See the TIOBE Index for September 2026, with Python still No. 1, Rust holding the top 10, and Julia nearing a return to the top 20. Rust held onto its place in the TIOBE Index top 10 in August 2026 ...

Plus: OpenAI has paused some model work over safety concerns. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology.

The BSN Pathway, ranked #1 in Alabama by U.S. News & World Report, is built on the UAB School of Nursing's 75-year history of educational excellence. The traditional four-year undergraduate curriculum ...

Global Entry can shorten your wait at security and U.S. Customs. It's a great value, even for infrequent travelers. When you travel internationally, you have to clear U.S. Customs before being allowed ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...